CD19 and systemic lupus erythematosus: This approach enabled us to study the global effect of a defined CD19 CAR T cell–mediated depletion of B cells on the immune status of patients with SLE and to consequently understand the precise contribution of B cell (auto-)reactivity to the molecular immune pathogenesis of SLE.